Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
在体外和体内实验中，MEK 和 AKT 抑制剂联合治疗比单独使用任何一种药物治疗人类非小细胞肺癌都更有效
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0014124
Meng Jieru, Dai Bingbing, Fang Bingliang, Bekele B Nebiyou, Bornmann William G, Sun Duoli, Peng Zhenghong, Herbst Roy S, Papadimitrakopoulou Vassiliki, Minna John D, Peyton Michael, Roth Jack A
